Harrold van Barlingen
Directeur Général chez Thuja Capital Management BV
Profil
Harrold van Barlingen is the founder of Thuja Capital Management BV, where he holds the title of Managing Partner since 2006.
He is also the founder of Thuja Capital Holding BV and Thuja Capital BV.
Currently, Dr. van Barlingen holds several positions, including Chairman-Supervisory Board at ATRO Medical BV, Chairman at Cytura Therapeutics BV, Director-Supervisory Board at Corgo NV, Non-Executive Director at Indigo Diabetes NV (starting in 2021), and Member of the Investment Committee at Centre for Drug Design & Discovery.
In the past, he has served as Chairman-Supervisory Board at Hemics BV, Independent Non-Executive Director at Galapagos NV (from 2005 to 2018), Director at DrugAbuse Sciences SAS, Non-Executive Director at Aratana Therapeutics NV, Non-Executive Director at TheraSolve NV, Director-Supervisory Board at EnCare Biotech BV, Principal at The Lewin Group, Inc., Investment Manager Life Sciences Investments at AlpInvest Partners BV (from 2005 to 2006), Member-Supervisory Board at Curacyte AG (from 2013 to 2014), Consultant-Management & Strategy at The Boston Consulting Group & Cie SARL (from 1999 to 2002), and Member-Supervisory Board at argenx SE (from 2008 to 2015).
Dr. van Barlingen has a graduate and doctorate degree from the University of Utrecht.
Dr. van Barlingen is also the founder of Thuja Capital Holding BV, Thuja Capital BV.
Postes actifs de Harrold van Barlingen
| Sociétés | Poste | Début |
|---|---|---|
Thuja Capital Management BV
 Thuja Capital Management BV Investment ManagersFinance Thuja Capital Management BV is a Venture Capital firm, a subsidiary of Thuja Capital Holding BV founded in 2006 by Harrold van Barlingen. Thuja Capital Management BV is headquartered in Utrecht. | Directeur Général | 01/04/2006 |
Corgo NV
 Corgo NV Miscellaneous Commercial ServicesCommercial Services Corgo NV specializes in corporate consulting services. The company determines the required profiles for client’s new directors, engages a network of professional external directors, recommends suitable candidates, and refers search specialists. It was founded by Karel Plasman in 2003 and is headquartered in Brussels, Belgium. | Directeur/Membre du Conseil | 05/05/2009 |
Thuja Capital BV
 Thuja Capital BV Investment ManagersFinance Thuja Capital BV invests in privately held early-stage biotechnology and medical device companies that are based in the Benelux. The fund can act as lead investor, although it also can co-invest alongside an international syndicate of VC investors. | Directeur Général | - |
Thuja Capital Holding BV
 Thuja Capital Holding BV Financial ConglomeratesFinance Thuja Capital Holding BV is a venture capital firm that manages multiple funds focused on building and scaling companies in the fields of pharmaceuticals, medtech, and digital health. The private company is based in Utrecht, Netherlands, and has subsidiaries in the Netherlands. The Dutch company's investments aim to generate a financial return for investors while positively impacting the health and well-being of patients. The company was founded by Harrold van Barlingen, who has been the CEO since incorporation. | Directeur Général | - |
Indigo Diabetes NV
 Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Directeur/Membre du Conseil | 12/05/2021 |
ATRO Medical BV
 ATRO Medical BV Medical SpecialtiesHealth Technology ATRO Medical BV develops trammpolin meniscus implants. The company was founded by Tony van Tienen and Jan Hunik on July 17, 2016 and is headquartered in Nijmegen, the Netherlands. | Président | - |
Centre for Drug Design & Discovery
 Centre for Drug Design & Discovery Centre for Drug Design & Discovery is a Private Equity/Venture Capital firm, a subsidiary of KU Leuven Research & Development and founded in 2006. Centre for Drug Design & Discovery is headquartered in Leuven. | Private Equity Investor | - |
Cytura Therapeutics BV
 Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Président | - |
Anciens postes connus de Harrold van Barlingen
| Sociétés | Poste | Fin |
|---|---|---|
| GALAPAGOS NV | Directeur/Membre du Conseil | 24/04/2018 |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Harrold van Barlingen
| University of Utrecht | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| ARGENX SE | Health Technology |
| Entreprise privées | 17 |
|---|---|
The Lewin Group, Inc.
 The Lewin Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lewin Group, Inc. operates as a health care and human services consulting firm. Its services include modeling, statistics, and actuarial analysis, policy research and data analysis, program effectiveness, strategic planning, and technical assistance. The company was founded by Lawrence S. Lewin in 1970 and is headquartered in Falls Church, VA. | Commercial Services |
AlpInvest Partners BV
 AlpInvest Partners BV Investment ManagersFinance AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands. | Finance |
Curacyte AG
 Curacyte AG Miscellaneous Commercial ServicesCommercial Services Curacyte AG develops and markets biopharmaceutical solutions. The firm specializes in the development of new therapeutics for acute and critical care applications. Its focus areas cover applications in hematology, antithrombosism, and oncology. Its pipeline and development portfolio encompasses technologies, such as hemoximers, distributive shock, cardiogenic shock, plasmin and plasma kallikrei, matriptase, and high-dose interleukin-2 therapy. The company was founded in February 2000 and is headquartered in Munich, Germany. | Commercial Services |
DrugAbuse Sciences SAS
 DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | Health Technology |
Corgo NV
Corgo NV Miscellaneous Commercial ServicesCommercial Services Corgo NV specializes in corporate consulting services. The company determines the required profiles for client’s new directors, engages a network of professional external directors, recommends suitable candidates, and refers search specialists. It was founded by Karel Plasman in 2003 and is headquartered in Brussels, Belgium. | Commercial Services |
Thuja Capital Management BV
Thuja Capital Management BV Investment ManagersFinance Thuja Capital Management BV is a Venture Capital firm, a subsidiary of Thuja Capital Holding BV founded in 2006 by Harrold van Barlingen. Thuja Capital Management BV is headquartered in Utrecht. | Finance |
Thuja Capital Holding BV
Thuja Capital Holding BV Financial ConglomeratesFinance Thuja Capital Holding BV is a venture capital firm that manages multiple funds focused on building and scaling companies in the fields of pharmaceuticals, medtech, and digital health. The private company is based in Utrecht, Netherlands, and has subsidiaries in the Netherlands. The Dutch company's investments aim to generate a financial return for investors while positively impacting the health and well-being of patients. The company was founded by Harrold van Barlingen, who has been the CEO since incorporation. | Finance |
Aratana Therapeutics NV
 Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium. | Health Technology |
The Boston Consulting Group & Cie SARL
 The Boston Consulting Group & Cie SARL Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group & Cie SARL provides management consulting services. Its practice areas include branding, marketing, corporate finance, globalization, and information technology. The company is a subsidiary of The Boston Consulting Group. The firm was founded in 1972 and is headquartered in Paris, France. | Commercial Services |
TheraSolve NV
 TheraSolve NV BiotechnologyHealth Technology TheraSolve NV operates as a medical technology company that develops and commercializes solutions to promote medication adherence. The firm develops MemoPatch, an electronic reminder system that supports and motivates patients to take their medication regularly. The company was founded by Wim de Geest, Jan de Geest, Denise de Geest, Sabina de Geest, Corrine Flejou and Jan van Driessche in 2009 and is headquartered in Diepenbeek, Belgium. | Health Technology |
Hemics BV
 Hemics BV Medical SpecialtiesHealth Technology Hemics BV develops and manufactures medical imaging devices. Its systems are based on patented optical inflammation detection technology, a non-invasive, fast and operator independent method that supports rheumatologists in objective assessment of inflammatory status, a key parameter in the treatment of patients with RA. The company was founded by Wouter Rensen, Michiel van Beek and Petra van den Elsen on September 1, 2011 and is headquartered in Eindhoven, the Netherlands. | Health Technology |
Thuja Capital BV
Thuja Capital BV Investment ManagersFinance Thuja Capital BV invests in privately held early-stage biotechnology and medical device companies that are based in the Benelux. The fund can act as lead investor, although it also can co-invest alongside an international syndicate of VC investors. | Finance |
EnCare Biotech BV
 EnCare Biotech BV Medical/Nursing ServicesHealth Services EnCare Biotech BV operates as a biopharmaceutical company which develops therapeutic antibody for the prevention of heart failure after acute myocardial infarction. Its product is a novel therapeutic monoclonal antibody against the EDA fragment of fibronectin. The company was founded by Fatih Arslan in 2014 and is headquartered in Utrecht, the Netherlands. | Health Services |
Indigo Diabetes NV
Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Health Technology |
ATRO Medical BV
ATRO Medical BV Medical SpecialtiesHealth Technology ATRO Medical BV develops trammpolin meniscus implants. The company was founded by Tony van Tienen and Jan Hunik on July 17, 2016 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Commercial Services |
Centre for Drug Design & Discovery
Centre for Drug Design & Discovery Centre for Drug Design & Discovery is a Private Equity/Venture Capital firm, a subsidiary of KU Leuven Research & Development and founded in 2006. Centre for Drug Design & Discovery is headquartered in Leuven. |
